Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation
Read more at MarketWatch
Topics
-
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Business - CNBC - October 31 -
An Australian on trial for drugs in Japan says she's the victim of a romance scam
World - ABC News - Yesterday -
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Tech - Wired - October 23 -
AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say
Business - MarketWatch - November 12 -
Cancer patient in Wales denied life-extending drug
Top stories - BBC News - 4 days ago -
10 MLB offseason bold predictions: Juan Soto contract breaks Shohei Ohtani's record, Mets blockbuster, more
Sports - CBS Sports - November 9 -
Blockbuster Matches Present Big Tests Yet for Four New Soccer Coaches
Sports - The New York Times - October 26 -
UK trial to assess if red grape chemical can prevent bowel cancer
World - The Guardian - November 11
More from MarketWatch
-
Trump picking Warsh for Treasury would empower a critic of both the Fed and tariffs
Business - MarketWatch - 18 minutes ago -
Amazon is beating other retailers on price, but here’s how you can beat Amazon
Business - MarketWatch - 36 minutes ago -
RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.
Business - MarketWatch - 42 minutes ago -
Nvidia earnings are on deck. Here are the 5 big things to know.
Business - MarketWatch - 54 minutes ago -
Here’s what bond and gold traders are signaling about Russia’s nuclear shift
Business - MarketWatch - 1 hour ago